Viruses and interferon: a fight for supremacy
The DOI matches its Crossref record; 139 of the 139 references it cites were found in a registry or an index.
Abstract
The action of interferons (IFNs) on virus-infected cells and surrounding tissues elicits an antiviral state that is characterized by the expression and antiviral activity of IFN-stimulated genes. In turn, viruses encode mechanisms to counteract the host response and support efficient viral replication, thereby minimizing the therapeutic antiviral power of IFNs. In this review, we discuss the interplay between the IFN system and four medically important and challenging viruses -- influenza, hepatitis C, herpes simplex and vaccinia -- to highlight the diversity of viral strategies. Understanding the complex network of cellular antiviral processes and virus-host interactions should aid in identifying new and common targets for the therapeutic intervention of virus infection. This effort must take advantage of the recent developments in functional genomics, bioinformatics and other emerging technologies.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“A pivotal study in 1987 reported that a subpopulation of people with viral hepatitis treated with interferon (IFN) α — a pro-inflammatory anti-viral cytokine13 — developed depression14, demonstrating that a pro-inflammatory molecule in the periphery could directly influence mood.”
From Central regulation of stress-evoked peripheral immune responses (2023) · cites this paper as [13]
In the citing paper
“The ISG expression of all monocytes combined and all macrophages combined was higher in HCV infection compared with NS–SS and MASH (Extended Data Fig. 4e), consistent with the role of ISGs as antiviral effectors11.”
In the citing paper
“Neutrophil recruitment is induced mainly by epithelium-derived IL-8/CXCL8, Gro-α/CXCL1, and ENA-78/CXCL5 (142, 178, 223).”
From The airway epithelium: soldier in the fight against respiratory viruses (2011) · cites this paper as [142]
Citations
Cites
Massagué, J. (1998) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.67.1.753 · Cited by 7,556
Recognition of double-stranded RNA and activation of NF-κB by Toll-like receptor 3
Alexopoulou, L., Holt, A. C., Medzhitov, R., & Flavell, R. A. (2001) · Nature · doi:10.1038/35099560 · Cited by 6,129
A comprehensive analysis of protein–protein interactions in Saccharomyces cerevisiae
Uetz, P., Giot, L., Cagney, G., Mansfield, T. A., Judson, R. S., Knight, J. R., Lockshon, D., Narayan, V., Srinivasan, M., Pochart, P., et al. (2000) · Nature · doi:10.1038/35001009 · Cited by 4,706 · cited 1×
“, and to characterize global protein–protein interaction networks in an organis”
BackgroundVirus interference. I. the interferon
Isaacs, A., & Lindenmann, J. (1957) · Proceedings of the Royal Society of London. Series B - Biological Sciences · doi:10.1098/rspb.1957.0048 · Cited by 3,451
Toll-like receptors in the induction of the innate immune response
Aderem, A., & Ulevitch, R. J. (2000) · Nature · doi:10.1038/35021228 · Cited by 3,064
Replication of Subgenomic Hepatitis C Virus RNAs in a Hepatoma Cell Line
Lohmann, V., Körner, F., Koch, J.-O., Herian, U., Theilmann, L., & Bartenschlager, R. (1999) · Science · doi:10.1126/science.285.5424.110 · Cited by 2,814
Antiviral Actions of Interferons
Samuel, C. E. (2001) · Clinical Microbiology Reviews · doi:10.1128/cmr.14.4.778-809.2001 · Cited by 2,743 · cited 1×
“gif" NDATA ITEM> ]> Interferons (IFNs), although best known for their antiviral propertie”
Integrated Genomic and Proteomic Analyses of a Systematically Perturbed Metabolic Network
Ideker, T., Thorsson, V., Ranish, J. A., Christmas, R., Buhler, J., Eng, J. K., Bumgarner, R., Goodlett, D. R., Aebersold, R., & Hood, L. (2001) · Science · doi:10.1126/science.292.5518.929 · Cited by 2,050 · cited 1×
“This confluence of genomic and information technologies brings a powerful new approach to the study of biological systems, as exemplified by recent studie”
BackgroundDer, S. D., Zhou, A., Williams, B. R. G., & Silverman, R. H. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.26.15623 · Cited by 1,816
A N EW A PPROACH TO D ECODING L IFE : Systems Biology
Ideker, T., Galitski, T., & Hood, L. (2001) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev.genom.2.1.343 · Cited by 1,664 · cited 1×
“Together, these technologies provide a global perspective on the complex interactions that occur between all levels of biological information ('systems biology'), from gene expression to protein productio”
Background
Research works printed but not linked: 7
- Biron, C. A. & Sen, G. C. in Fields Virology (eds Knipe, D. M. & Howley, P. M.) 321–352 (Lippincott, Williams & Wilkins, Philadelphia, 2001).
- Witherell, G. W. & Beineke, P. Statistical analysis of combined substitutions in nonstructural 5A region of hepatitis C virus and interferon response. J. Med. Virol. 63, 8–16 (2001). · doi:10.1002/1096-9071(200101)63:1<8::aid-jmv1001>3.0.co;2-k
- Sumpter, R. Jr & Gale, M. Jr. in American Society for Virology 21st Annual Meeting W33-3 (Lexington, Kentucky, 2002).
- Whitley, R. J. in Fields Virology (eds Knipe, D. M. & Howley, P. M.) 2461–2509 (Lippincott, Williams & Wilkins, Philadelphia, 2001).
- Roizman, B. & Knipe, D. M. in Fields Virology (eds Knipe, D. M. & Howley, P. M.) 2399–2460 (Lippincott, Williams & Wilkins, Philadelphia, 2001).
- Esposito, J. J. & Fenner, F. in Fields Virology (eds Knipe, D. M. & Howley, P. M.) 2849–2884 (Lippincott, Williams & Wilkins, Philadelphia, 2001).
- Moss, B. in Fields Virology (eds Knipe, D. M. & Howley, P. M.) 2885–2922 (Lippincott, Williams & Wilkins, Philadelphia, 2001).
Cited by
Toll-like receptor control of the adaptive immune responses
Iwasaki, A., & Medzhitov, R. (2004) · Nature Immunology · doi:10.1038/ni1112 · Cited by 4,193
“The function of type I interferons in adaptive immunity The type I interferon family consists of IFN-α, IFN-β, IFN-ω and IFN-&lambda”
BackgroundDifferential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses
Kato, H., Takeuchi, O., Sato, S., Yoneyama, M., Yamamoto, M., Matsui, K., Uematsu, S., Jung, A., Kawai, T., Ishii, K. J., et al. (2006) · Nature · doi:10.1038/nature04734 · Cited by 3,888
Mechanisms of type-I- and type-II-interferon-mediated signalling
Platanias, L. C. (2005) · Nature Reviews Immunology · doi:10.1038/nri1604 · Cited by 3,491
“, indicating that the p38-signalling pathway has an important role in the induction of the therapeutic effects of IFN-α in patients who have HCV-induced hepatiti”
BackgroundDelivery technologies for cancer immunotherapy
Riley, R. S., June, C. H., Langer, R., & Mitchell, M. J. (2019) · Nature Reviews Drug Discovery · doi:10.1038/s41573-018-0006-z · Cited by 2,607
Recognition of single-stranded RNA viruses by Toll-like receptor 7
Lund, J. M., Alexopoulou, L., Sato, A., Karow, M., Adams, N. C., Gale, N. W., Iwasaki, A., & Flavell, R. A. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0400937101 · Cited by 1,861
Robust hepatitis C virus infection in vitro
Zhong, J., Gastaminza, P., Cheng, G., Kapadia, S., Kato, T., Burton, D. R., Wieland, S. F., Uprichard, S. L., Wakita, T., & Chisari, F. V. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0503596102 · Cited by 1,709
The Adaptor Protein MITA Links Virus-Sensing Receptors to IRF3 Transcription Factor Activation
Zhong, B., Yang, Y., Li, S., Wang, Y.-Y., Li, Y., Diao, F., Lei, C., He, X., Zhang, L., Tien, P., et al. (2008) · Immunity · doi:10.1016/j.immuni.2008.09.003 · Cited by 1,519
“Viral infection triggers a series of signaling events that lead to induction of type I interferons (IFNs), including IFN-b and IFN-a family cytokines (Akira et al., 2006; Fitzgerald et al., 2003; Hiscott, 2007; Honda et al., 2006; Katze et al., 2002).”
BackgroundType I interferons in anticancer immunity
Zitvogel, L., Galluzzi, L., Kepp, O., Smyth, M. J., & Kroemer, G. (2015) · Nature Reviews Immunology · doi:10.1038/nri3845 · Cited by 1,305
The Genome Sequence of Taurine Cattle: A Window to Ruminant Biology and Evolution
The Bovine Genome Sequencing and Analysis Consortium, Elsik, C. G., Tellam, R. L., Worley, K. C., Gibbs, R. A., Muzny, D. M., Weinstock, G. M., Adelson, D. L., Eichler, E. E., Elnitski, L., et al. (2009) · Science · doi:10.1126/science.1169588 · Cited by 1,287
Toll-like Receptor 9–mediated Recognition of Herpes Simplex Virus-2 by Plasmacytoid Dendritic Cells
Lund, J., Sato, A., Akira, S., Medzhitov, R., & Iwasaki, A. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20030162 · Cited by 1,198
“Type I IFNs have an essential role in antiviral defense (12), mediated by pathways involving PKR and 2 -5 oligoadenylate synthetase (13).”
Genomic analysis of the host response to hepatitis C virus infection
Su, A. I., Pezacki, J. P., Wodicka, L., Brideau, A. D., Supekova, L., Thimme, R., Wieland, S., Bukh, J., Purcell, R. H., Schultz, P. G., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.202608199 · Cited by 1,161
Li, K., Foy, E., Ferreon, J. C., Nakamura, M., Ferreon, A. C. M., Ikeda, M., Ray, S. C., Gale, M., & Lemon, S. M. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0408824102 · Cited by 1,092
Self-citationJego, G., Palucka, A. K., Blanck, J.-P., Chalouni, C., Pascual, V., & Banchereau, J. (2003) · Immunity · doi:10.1016/s1074-7613(03)00208-5 · Cited by 1,067
“In particular, IFN- Summary acts directly on most cell types to turn on biochemical pathways that restrict viral replication and render host Dendritic cells (DCs) initiate and control immune recells resistant to further viral infection (Katze et al., 2002). sponses.”
BackgroundPhetsouphanh, C., Darley, D. R., Wilson, D. B., Howe, A., Munier, C. M. L., Patel, S. K., Juno, J. A., Burrell, L. M., Kent, S. J., Dore, G. J., et al. (2022) · Nature Immunology · doi:10.1038/s41590-021-01113-x · Cited by 1,015
Mechanism of action of interferon and ribavirin in treatment of hepatitis C
Feld, J. J., & Hoofnagle, J. H. (2005) · Nature · doi:10.1038/nature04082 · Cited by 992
“These studies highlight the complexity of teasing out the actions of HCV proteins on the often-multitiered IFN signalling pathways during acute and chronic infection, and during therapy of hepatitis”
BackgroundCommensal bacteria calibrate the activation threshold of innate antiviral immunity
Abt, M. C., Osborne, L. C., Monticelli, L. A., Doering, T. A., Alenghat, T., Sonnenberg, G. F., Paley, M. A., Antenus, M., Williams, K. L., Erikson, J., et al. (2012) · Immunity · doi:10.1016/j.immuni.2012.04.011 · Cited by 993
Toll-like receptor 3 promotes cross-priming to virus-infected cells
Schulz, O., Diebold, S. S., Chen, M., Näslund, T. I., Nolte, M. A., Alexopoulou, L., Azuma, Y.-T., Flavell, R. A., Liljeström, P., & Reis e Sousa, C. (2005) · Nature · doi:10.1038/nature03326 · Cited by 921
“This may represent the situation that arises during infection with viruses that block IFN-α/β productio”
BackgroundSumpter, R., Loo, Y.-M., Foy, E., Li, K., Yoneyama, M., Fujita, T., Lemon, S. M., & Gale, M. (2005) · Journal of Virology · doi:10.1128/jvi.79.5.2689-2699.2005 · Cited by 898
“The specificity of this assay for dsRNA binding proteins was confirmed by the recovery of endogenous PKR, a known dsRNA binding protein (12), but not endogenous actin.”
BackgroundInfluentialSelf-citationProal, A. D., & VanElzakker, M. B. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.698169 · Cited by 876
Type 1 Interferons and the Virus-Host Relationship: A Lesson in Détente
García-Sastre, A., & Biron, C. A. (2006) · Science · doi:10.1126/science.1125676 · Cited by 885
HSV-1 ICP34.5 Confers Neurovirulence by Targeting the Beclin 1 Autophagy Protein
Orvedahl, A., Alexander, D., Tallóczy, Z., Sun, Q., Wei, Y., Zhang, W., Burns, D., Leib, D. A., & Levine, B. (2007) · Cell Host & Microbe · doi:10.1016/j.chom.2006.12.001 · Cited by 857
Interferon modulation of cellular microRNAs as an antiviral mechanism
Pedersen, I. M., Cheng, G., Wieland, S., Volinia, S., Croce, C. M., Chisari, F. V., & David, M. (2007) · Nature · doi:10.1038/nature06205 · Cited by 849
Takaoka, A., Hayakawa, S., Yanai, H., Stoiber, D., Negishi, H., Kikuchi, H., Sasaki, S., Imai, K., Shibue, T., Honda, K., et al. (2003) · Nature · doi:10.1038/nature01850 · Cited by 847
Regulation of Interferon Regulatory Factor-3 by the Hepatitis C Virus Serine Protease
Foy, E., Li, K., Wang, C., Sumpter, R., Ikeda, M., Lemon, S. M., & Gale, M. (2003) · Science · doi:10.1126/science.1082604 · Cited by 788
Self-citationTRIM family proteins: retroviral restriction and antiviral defence
Nisole, S., Stoye, J. P., & Saïb, A. (2005) · Nature Reviews Microbiology · doi:10.1038/nrmicro1248 · Cited by 761
Krug, A., French, A. R., Barchet, W., Fischer, J. A. A., Dzionek, A., Pingel, J. T., Orihuela, M. M., Akira, S., Yokoyama, W. M., & Colonna, M. (2004) · Immunity · doi:10.1016/j.immuni.2004.06.007 · Cited by 727
Krug, A., Luker, G. D., Barchet, W., Leib, D. A., Akira, S., & Colonna, M. (2004) · Blood · doi:10.1182/blood-2003-08-2674 · Cited by 695
Structural biology of hepatitis C virus
Penin, F., Dubuisson, J., Rey, F. A., Moradpour, D., & Pawlotsky, J.-M. (2004) · Hepatology · doi:10.1002/hep.20032 · Cited by 683
Seet, B. T., Johnston, J. B., Brunetti, C. R., Barrett, J. W., Everett, H., Cameron, C., Sypula, J., Nazarian, S. H., Lucas, A., & McFadden, G. (2003) · Annual Review of Immunology · doi:10.1146/annurev.immunol.21.120601.141049 · Cited by 666
The airway epithelium: soldier in the fight against respiratory viruses
Vareille, M., Kieninger, E., Edwards, M. R., & Regamey, N. (2011) · Clinical Microbiology Reviews · doi:10.1128/cmr.00014-10 · Cited by 655
“They bind to the type I IFN receptor complex (IFNAR1 and -2) and induce a range of different genes encoding proteins that selectively interfere with virus replication, protein synthesis, or protein trafficking (16, 139, 245).”
BackgroundGenomic analysis of the host response to hepatitis B virus infection
Wieland, S., Thimme, R., Purcell, R. H., & Chisari, F. V. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0401771101 · Cited by 652
Rothenfusser, S., Goutagny, N., DiPerna, G., Gong, M., Monks, B. G., Schoenemeyer, A., Yamamoto, M., Akira, S., & Fitzgerald, K. A. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.8.5260 · Cited by 643
Evasion of intracellular host defence by hepatitis C virus
Gale, M., & Foy, E. M. (2005) · Nature · doi:10.1038/nature04078 · Cited by 633
“To replicate and spread successfully, viruses direct various strategies to evade host defence”
Self-citationMacrophage Polarisation: an Immunohistochemical Approach for Identifying M1 and M2 Macrophages
Barros, M. H. M., Hauck, F., Dreyer, J. H., Kempkes, B., & Niedobitek, G. (2013) · PLoS ONE · doi:10.1371/journal.pone.0080908 · Cited by 594
“STAT1 is upregulated in response to types I, II or III interferons and its phosphorylated form (pSTAT1) binds to the promoter region of interferon-stimulated genes [4,17].”
BackgroundResultViral infection switches non-plasmacytoid dendritic cells into high interferon producers
Diebold, S. S., Montoya, M., Unger, H., Alexopoulou, L., Roy, P., Haswell, L. E., Al-Shamkhani, A., Flavell, R., Borrow, P., & Sousa, C. R. E. (2003) · Nature · doi:10.1038/nature01783 · Cited by 582
“The viral components leading to IFN-I induction remain largely unidentifie”
BackgroundInterferon signalling network in innate defence
Takaoka, A., & Yanai, H. (2006) · Cellular Microbiology · doi:10.1111/j.1462-5822.2006.00716.x · Cited by 581
Marcello, T., Grakoui, A., Barba–Spaeth, G., Machlin, E. S., Kotenko, S. V., Macdonald, M. R., & Rice, C. M. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.09.052 · Cited by 561
The interferon system of teleost fish
Robertsen, B. (2006) · Fish & Shellfish Immunology · doi:10.1016/j.fsi.2005.01.010 · Cited by 561
Foy, E., Li, K., Sumpter, R., Loo, Y.-M., Johnson, C. L., Wang, C., Fish, P. M., Yoneyama, M., Fujita, T., Lemon, S. M., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0408707102 · Cited by 548
Self-citationMcFadden, G. (2005) · Nature Reviews Microbiology · doi:10.1038/nrmicro1099 · Cited by 523
Ge, Q., McManus, M. T., Nguyen, T., Shen, C.-H., Sharp, P. A., Eisen, H. N., & Chen, J. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0437841100 · Cited by 526
The evolution of RNAi as a defence against viruses and transposable elements
Obbard, D. J., Gordon, K. H. J., Buck, A. H., & Jiggins, F. M. (2009) · Philosophical Transactions of the Royal Society B: Biological Sciences · doi:10.1098/rstb.2008.0168 · Cited by 516
“(b) Viral suppression and evasion of the viRNA pathway Viral suppression of the immune system is a widespread phenomenon (e.g. Katze et al. 2002; Marques & Carthew 2007).”
Hendra and Nipah viruses: different and dangerous
Eaton, B. T., Broder, C. C., Middleton, D., & Wang, L.-F. (2006) · Nature Reviews Microbiology · doi:10.1038/nrmicro1323 · Cited by 482
“Over millions of years of co-evolution, almost all viruses have evolved ways to evade the IFN-induced antiviral responses of their host”
BackgroundThe Ebola Virus VP35 Protein Inhibits Activation of Interferon Regulatory Factor 3
Basler, C. F., Mikulasova, A., Martinez-Sobrido, L., Paragas, J., Mühlberger, E., Bray, M., Klenk, H.-D., Palese, P., & García-Sastre, A. (2003) · Journal of Virology · doi:10.1128/jvi.77.14.7945-7956.2003 · Cited by 477
“The developing genomics and proteomics technologies also hold great promise in helping to define the impact of viral infection and viral gene expression on the host cell (37).”
BackgroundThe Yin and Yang of type I interferon activity in bacterial infection
Decker, T., Müller, M., & Stockinger, S. (2005) · Nature Reviews Immunology · doi:10.1038/nri1684 · Cited by 468
“All IFNs are named after their ability to stimulate the synthesis of a large set of antiviral gene products and therefore to limit viral replication and sprea”
BackgroundInduction and Regulation of IFNs During Viral Infections
Malmgaard, L. (2004) · Journal of Interferon & Cytokine Research · doi:10.1089/1079990041689665 · Cited by 454
Negishi, H., Taniguchi, T., & Yanai, H. (2018) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a028423 · Cited by 445
“All three classes of interferons (IFNs) are so named because of the shared property to interfere with viral replication in the host (Weissmann and Weber 1986; Taniguchi 1988; Stark et al. 1998; Levy and Garcia-Sastre 2001; Samuel 2001; Katze et al. 2002; Pestka et al. 2004; Platanias 2005; Vilcek 2006).”
BackgroundInfluentialSioud, M. (2005) · Journal of Molecular Biology · doi:10.1016/j.jmb.2005.03.013 · Cited by 418
Cullen, B. R. (2006) · Nature Genetics · doi:10.1038/ng1793 · Cited by 404
“On the basis of the activities associated with viral nonstructural proteins, however, one can predict that viral miRNAs probably inhibit aspects of the host adaptive immune response, including antigen presentation, or the innate immune response, including induction of apoptosis or the interferon syste”
BackgroundPerry, A. K., Chow, E. K., Goodnough, J. B., Yeh, W.-C., & Cheng, G. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20040528 · Cited by 399
“Viruses can inhibit induction of type I IFNs in a variety of ways, many of which have not yet been elucidated, and further understanding of these pathways can help to better understand the mechanisms of virus-mediated inhibition of the IFN response (46).”
BackgroundThe role of RNAi and microRNAs in animal virus replication and antiviral immunity
Umbach, J. L., & Cullen, B. R. (2009) · Genes & Development · doi:10.1101/gad.1793309 · Cited by 383
“In mammalian cells, viral infection is a potent trigger of the interferon (IFN) response (for review, see Sen 2001; Katze et al. 2002; Sadler andWilliams 2008).”
BackgroundHasan, U. A., Bates, E., Takeshita, F., Biliato, A., Accardi, R., Bouvard, V., Mansour, M., Vincent, I., Gissmann, L., Iftner, T., et al. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.5.3186 · Cited by 380
Toll-Like Receptors and RNA Helicases: Two Parallel Ways to Trigger Antiviral Responses
Meylan, E., & Tschopp, J. (2006) · Molecular Cell · doi:10.1016/j.molcel.2006.05.012 · Cited by 372
The host type I interferon response to viral and bacterial infections
PERRY, A. K., CHEN, G., ZHENG, D., TANG, H., & CHENG, G. (2005) · Cell Research · doi:10.1038/sj.cr.7290309 · Cited by 360
“The potency of PKR in host anti-viral responses is highlighted by the numerous viruses that encode genes to inhibit PKR activity”
BackgroundTemporal Analysis of Early Immune Responses in Patients With Acute Hepatitis B Virus Infection
Dunn, C., Peppa, D., Khanna, P., Nebbia, G., Jones, M., Brendish, N., Lascar, R. M., Brown, D., Gilson, R. J., Tedder, R. J., et al. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.06.054 · Cited by 362
Epidemiology and Immune Pathogenesis of Viral Sepsis
Lin, G.-L., McGinley, J. P., Drysdale, S. B., & Pollard, A. J. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02147 · Cited by 351
“Dengue virus also activates the TLR7, TLR8, RIG-I and MDA5 signalling pathways, which signal through type I IFNs (194–196).”
BackgroundInfluentialRegulation of the type I IFN induction: a current view
Honda, K., Yanai, H., Takaoka, A., & Taniguchi, T. (2005) · International Immunology · doi:10.1093/intimm/dxh318 · Cited by 348
Best, S. M., Morris, K. L., Shannon, J. G., Robertson, S. J., Mitzel, D. N., Park, G. S., Boer, E., Wolfinbarger, J. B., & Bloom, M. E. (2005) · Journal of Virology · doi:10.1128/jvi.79.20.12828-12839.2005 · Cited by 325
“Both RNA and DNA viruses utilize a variety of mechanisms to inhibit IFN-stimulated JAK-STAT signaling (5, 11, 13, 22, 28).”
BackgroundBrzózka, K., Finke, S., & Conzelmann, K.-K. (2005) · Journal of Virology · doi:10.1128/jvi.79.12.7673-7681.2005 · Cited by 321
High CD46 Receptor Density Determines Preferential Killing of Tumor Cells by Oncolytic Measles Virus
Anderson, B. D., Nakamura, T., Russell, S. J., & Peng, K.-W. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0884 · Cited by 315
“One of the most important defense mechanism a cell has against viral infection is induction of IFN-/ and IFN-inducible proteins, resulting in suppression of protein synthesis and establishment of an antiviral state ( 9 , 10).”
BackgroundReview: On the Role of IRF in Host Defense
Barnes, B., Lubyova, B., & Pitha, P. M. (2002) · Journal of Interferon & Cytokine Research · doi:10.1089/107999002753452665 · Cited by 318
The Ebola Virus VP35 Protein Is a Suppressor of RNA Silencing
Haasnoot, J., de Vries, W., Geutjes, E.-J., Prins, M., de Haan, P., & Berkhout, B. (2007) · PLoS Pathogens · doi:10.1371/journal.ppat.0030086 · Cited by 317
“The fact that many RSS proteins also have IFN antagonistic properties [50–56] supports the idea that RNAi and IFN responses work together against invading viruses.”
BackgroundHuman infection with highly pathogenic H5N1 influenza virus
Gambotto, A., Barratt-Boyes, S. M., de Jong, M. D., Neumann, G., & Kawaoka, Y. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60627-3 · Cited by 316
Translational control of the innate immune response through IRF-7
Colina, R., Costa-Mattioli, M., Dowling, R. J. O., Jaramillo, M., Tai, L.-H., Breitbach, C. J., Martineau, Y., Larsson, O., Rong, L., Svitkin, Y. V., et al. (2008) · Nature · doi:10.1038/nature06730 · Cited by 316
Liu, W. J., Wang, X. J., Mokhonov, V. V., Shi, P.-Y., Randall, R., & Khromykh, A. A. (2005) · Journal of Virology · doi:10.1128/jvi.79.3.1934-1942.2005 · Cited by 308
“Gamma IFN (IFN- ) is IFN that is usually produced by specific cells of the immune system, including CD8 T cells, and has potent antiviral and immunomodulating activities (7, 16, 17, 28).”
BackgroundMenachery, V. D., Eisfeld, A. J., Schäfer, A., Josset, L., Sims, A. C., Proll, S., Fan, S., Li, C., Neumann, G., Tilton, S. C., et al. (2014) · mBio · doi:10.1128/mbio.01174-14 · Cited by 305
“While several IFN-independent ISGs exist, the vast majority of genes are augmented by IFN production (9); naturally, both CoV and influenza family members have developed approaches to prevent this induction by disturbing the sensing pathways (10, 11).”
BackgroundSelf-citationStructure and Function of the Membrane Anchor Domain of Hepatitis C Virus Nonstructural Protein 5A
Penin, F., Brass, V., Appel, N., Ramboarina, S., Montserret, R., Ficheux, D., Blum, H. E., Bartenschlager, R., & Moradpour, D. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m404761200 · Cited by 301
He, B., Qiao, X., & Cerutti, A. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.7.4479 · Cited by 296
“CpG DNA would further enhance TD IgG production by favoring the release of IFN- (19, 22), a powerful inducer of key T cell-costimulating molecules on APCs (21).”
BackgroundHu, Y., Li, W., Gao, T., Cui, Y., Jin, Y., Li, P., Ma, Q., Liu, X., & Cao, C. (2017) · Journal of Virology · doi:10.1128/jvi.02143-16 · Cited by 294
“Virus-encoded proteins also target IFN genes and IFN-induced genes to prevent host antiviral effector responses (2, 9).”
BackgroundAutoimmunity through Cytokine-Induced Dendritic Cell Activation
Banchereau, J., Pascual, V., & Palucka, A. K. (2004) · Immunity · doi:10.1016/s1074-7613(04)00108-6 · Cited by 293
Toll-like Receptors are Key Participants in Innate Immune Responses
ARANCIBIA, S. A., BELTRÁN, C. J., AGUIRRE, I. M., SILVA, P., PERALTA, A. L., MALINARICH, F., & HERMOSO, M. A. (2007) · Biological Research · doi:10.4067/s0716-97602007000200001 · Cited by 289
“Host defense against virus involves IFN type I production that leads to IFN-stimulated gene expression, with the resulting activation of antiviral, antiproliferative and immunoregulatory responses (119).”
Hernández, P. P., Mahlakõiv, T., Yang, I., Schwierzeck, V., Nguyen, N., Guendel, F., Gronke, K., Ryffel, B., Hölscher, C., Dumoutier, L., et al. (2015) · Nature Immunology · doi:10.1038/ni.3180 · Cited by 287
Cationic liposome-mediated delivery of siRNAs in adult mice
Sioud, M., & Sørensen, D. R. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2003.11.057 · Cited by 286
Lin, R.-J., Chang, B.-L., Yu, H.-P., Liao, C.-L., & Lin, Y.-L. (2006) · Journal of Virology · doi:10.1128/jvi.02714-05 · Cited by 286
STAT Protein Interference and Suppression of Cytokine Signal Transduction by Measles Virus V Protein
Palosaari, H., Parisien, J.-P., Rodriguez, J. J., Ulane, C. M., & Horvath, C. M. (2003) · Journal of Virology · doi:10.1128/jvi.77.13.7635-7644.2003 · Cited by 285
“Many viruses encode gene products that are capable of inhibiting IFN systems (22).”
BackgroundDual recognition of herpes simplex viruses by TLR2 and TLR9 in dendritic cells
Sato, A., Linehan, M. M., & Iwasaki, A. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0605102103 · Cited by 278
Paun, A., & Pitha, P. M. (2007) · Biochimie · doi:10.1016/j.biochi.2007.01.014 · Cited by 272
“Finally the observation that many viruses prevent the induction of Type I IFN by targeting the function of IRF-3, and consequently the induction of Type I IFN genes, underlines the importance of IRF-3 in the induction of the antiviral response [69,70].”
BackgroundYang, K., Puel, A., Zhang, S., Eidenschenk, C., Ku, C.-L., Casrouge, A., Picard, C., von Bernuth, H., Senechal, B., Plancoulaine, S., et al. (2005) · Immunity · doi:10.1016/j.immuni.2005.09.016 · Cited by 272
“Five TLRs (TLR-3, -4, -7, -8, -9) have been shown to induce IFN-a/b and IFN-l production (Akira and Takeda, 2004; Coccia et al., 2004; Katze et al., 2002; Pestka et al., 2004).”
MethodLiu, W. J., Wang, X. J., Clark, D. C., Lobigs, M., Hall, R. A., & Khromykh, A. A. (2006) · Journal of Virology · doi:10.1128/jvi.80.5.2396-2404.2006 · Cited by 270
“However, IRF-3 is only one of many transcription factors involved in activation of IFN- transcription by viral infections (10, 18, 35), and a number of viral proteins from other viruses have been reported to block IRF-3 and/or other transcription factors (reviewed in references 10, 18, and 35; for more recent reviews,…”
BackgroundLin, R., Noyce, R. S., Collins, S. E., Everett, R. D., & Mossman, K. L. (2004) · Journal of Virology · doi:10.1128/jvi.78.4.1675-1684.2004 · Cited by 269
Avian reovirus: Structure and biology
Benavente, J., & Martínez-Costas, J. (2007) · Virus Research · doi:10.1016/j.virusres.2006.09.005 · Cited by 265
Class II cytokine receptors and their ligands: Key antiviral and inflammatory modulators
Renauld, J.-C. (2003) · Nature Reviews Immunology · doi:10.1038/nri1153 · Cited by 265
“The crucial role of class II cytokines and receptors during infection with viruses is best illustrated by the fact that many viruses have captured and subverted genes from this family, presumably to neutralize the host respons”
BackgroundDNA damage-induced type I interferon promotes senescence and inhibits stem cell function
Yu, Q., Katlinskaya, Y. V., Carbone, C. J., Zhao, B., Katlinski, K. V., Zheng, H., Guha, M., Li, N., Chen, Q., Yang, T., et al. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.03.069 · Cited by 260
“Here, we focused on type I interferons (IFN), anti-viral cytokines including IFN-b and IFN-a, that are expressed in response to activation of pathogen-associated molecular patterns under regulation of the IRF3 and IRF7 transcription factors, respectively (Katze et al., 2002).”
Interferons and Their Stimulated Genes in the Tumor Microenvironment
Cheon, H., Borden, E. C., & Stark, G. R. (2014) · Seminars in Oncology · doi:10.1053/j.seminoncol.2014.02.002 · Cited by 255
Minakshi, R., Padhan, K., Rani, M., Khan, N., Ahmad, F., & Jameel, S. (2009) · PLoS ONE · doi:10.1371/journal.pone.0008342 · Cited by 257
“Interferons (IFN) are synthesized and secreted by infected cells, and act on neighboring cells to elicit a variety of protective responses that limit the further spread of viral infection [64].”
BackgroundNULISA: a proteomic liquid biopsy platform with attomolar sensitivity and high multiplexing
Feng, W., Beer, J. C., Hao, Q., Ariyapala, I. S., Sahajan, A., Komarov, A., Cha, K., Moua, M., Qiu, X., Xu, X., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-42834-x · Cited by 247
Shaw, M. L., García-Sastre, A., Palese, P., & Basler, C. F. (2004) · Journal of Virology · doi:10.1128/jvi.78.11.5633-5641.2004 · Cited by 256
“Viruses have devised various strategies to circumvent this IFN-induced antiviral state through the expression of viral proteins that inhibit specific components of the IFN system (14, 29, 31).”
Backgroundvan der Molen, R. G., Sprengers, D., Binda, R. S., de Jong, E. C., Niesters, H. G. M., Kusters, J. G., Kwekkeboom, J., & Janssen, H. L. A. (2004) · Hepatology · doi:10.1002/hep.20366 · Cited by 257
Distinct Immune Response in Two MERS-CoV-Infected Patients: Can We Go from Bench to Bedside?
Faure, E., Poissy, J., Goffard, A., Fournier, C., Kipnis, E., Titecat, M., Bortolotti, P., Martinez, L., Dubucquoi, S., Dessein, R., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0088716 · Cited by 248
“Previous studies reported the critical role of IFNa, orchestrating the early immune response against viral infection, such as SARSCoV[1,7,15], by up-regulating the expression of MHC class I and II[4].”
BackgroundNewcastle Disease Virus V Protein Is a Determinant of Host Range Restriction
Park, M.-S., García-Sastre, A., Cros, J. F., Basler, C. F., & Palese, P. (2003) · Journal of Virology · doi:10.1128/jvi.77.17.9522-9532.2003 · Cited by 243
HCV-Induced miR-21 Contributes to Evasion of Host Immune System by Targeting MyD88 and IRAK1
Chen, Y., Chen, J., Wang, H., Shi, J., Wu, K., Liu, S., Liu, Y., & Wu, J. (2013) · PLoS Pathogens · doi:10.1371/journal.ppat.1003248 · Cited by 242
“However, viruses adopt various strategies to evade host defenses [46].”
BackgroundTRIM22 Inhibits Influenza A Virus Infection by Targeting the Viral Nucleoprotein for Degradation
Di Pietro, A., Kajaste-Rudnitski, A., Oteiza, A., Nicora, L., Towers, G. J., Mechti, N., & Vicenzi, E. (2013) · Journal of Virology · doi:10.1128/jvi.02548-12 · Cited by 240
“An integral component of the innate immune response active against IAV is the production of type I interferons (IFNs), which play a critical role in rendering host cells resistant to infection and favor the establishment of adaptive immunity effector responses (2).”
BackgroundPathophysiology of hepatitis C virus infection and related liver disease
Pawlotsky, J.-M. (2004) · Trends in Microbiology · doi:10.1016/j.tim.2003.12.005 · Cited by 241
Improved Vaccine against PRRSV: Current Progress and Future Perspective
Nan, Y., Wu, C., Gu, G., Sun, W., Zhang, Y.-J., & Zhou, E.-M. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.01635 · Cited by 240
“The cascade of events during activation of this pathway results in expression of IFN-stimulated genes (ISGs) (Katze et al., 2002), which include antiviral effectors to restrict virus replication.”
BackgroundThe role of Toll-like receptors in the host response to viruses
Bowie, A. G., & Haga, I. R. (2005) · Molecular Immunology · doi:10.1016/j.molimm.2004.11.007 · Cited by 239
Alphavirus-derived small RNAs modulate pathogenesis in disease vector mosquitoes
Myles, K. M., Wiley, M. R., Morazzani, E. M., & Adelman, Z. N. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0803408105 · Cited by 237
“It is possible that the IFN system has replaced the RNAi pathway as the primary antiviral response in mammals (40, 42).”
Chang, T.-H., Liao, C.-L., & Lin, Y.-L. (2006) · Microbes and Infection · doi:10.1016/j.micinf.2005.06.014 · Cited by 236
SARS coronavirus and innate immunity
Frieman, M., Heise, M., & Baric, R. (2008) · Virus Research · doi:10.1016/j.virusres.2007.03.015 · Cited by 235
HIV-1 infection of human macrophages directly induces viperin which inhibits viral production
Nasr, N., Maddocks, S., Turville, S. G., Harman, A. N., Woolger, N., Helbig, K. J., Wilkinson, J., Bye, C. R., Wright, T. K., Rambukwelle, D., et al. (2012) · Blood · doi:10.1182/blood-2012-01-407395 · Cited by 234
Brzózka, K., Finke, S., & Conzelmann, K.-K. (2006) · Journal of Virology · doi:10.1128/jvi.80.6.2675-2683.2006 · Cited by 233
“IFN expression and IFN effector functions are therefore vital targets of viruses (14, 17, 20 , 51).”
Background
Metadata
- Authors
- Katze, M. G., He, Y., & Gale, M.
- Affiliations
- University of Washington (US)
- The University of Texas Southwestern Medical Center (US)
- Corresponding author
- Katze, Michael G.
- Venue
- Nature Reviews Immunology
- Published
- 2002-09-01
- Volume
- 2
- Issue
- 9
- Pages
- 675-687
- ISSN
- 1474-1733 (ISSN-L)
- 1474-1741
- OpenAlex
- W2079295092
- Cited by
- 1,419
- References
- 138
- Citations by year
- 2026: 30 · 2025: 62 · 2024: 89 · 2023: 82 · 2022: 67 · 2021: 48 · 2020: 35 · 2019: 30 · 2018: 23 · 2017: 38 · 2016: 41 · 2015: 40 · 2014: 55 · 2013: 58 · 2012: 55
- FWCI
- 6.49
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springernature.com/gp/researchers/text-and-data-mining (tdm)
- www.springernature.com/gp/researchers/text-and-data-mining (vor)
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature reviews. Immunology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › interferon and immune responses
- Health Sciences › Medicine › Epidemiology › Virology and Viral Diseases
- Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
- Keywords
- interferon, antiviral immunity, host-virus interaction, interferon-stimulated genes, viral evasion of host defense, influenza virus, hepatitis C virus, herpes simplex virus, vaccinia virus, antiviral drug targets
- MeSH terms
- Animals, Hepatitis C, Herpes Simplex, Humans, Interferon Type I, Membrane Glycoproteins, Orthomyxoviridae, Orthomyxoviridae Infections, Receptors, Cell Surface, Vaccinia, Vaccinia virus, Virus Diseases, Virus Replication, Hepacivirus, Simplexvirus, Computational Biology, Databases as Topic, Genomics, Drosophila Proteins, Toll-Like Receptors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.